Home Nav
Nextech Invest Logo

William G. Kaelin

Alfred Scheidegger

William G. Kaelin MD is a professor of medicine, Harvard Medical School, USA. He is a member of the board of scientific advisors of the National Cancer Institute, USA, of the National Cancer Policy Board, Institute of Medicine, USA. Dr Kaelin serves as member of the board of directors of Eli Lilly and Company and the American Association for Cancer Research. He is involved with advisory provision to several oncology companies.

 

Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

06.09. – 09.09.2017

Mainz/Frankfurt, Germany

  • 25.07.2017

    Santen and TRACON announce initiation of a phase IIa...

  • 18.07.2017

    Kura Oncology announces issuance of U.S. patent for...

  • 13.07.2017

    Kura Oncology establishes collaboration with Foundation...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close